Mirae Asset Global Investments Co., Ltd.
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 1569395
SEOUL, M5
Position in NAMS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$177,176
-$14,787 QoQ
Shares Held
5,228
-12.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#161
of 198 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names. NAMS ranks #58 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,209 | $104,417,115 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
93,632 | $58,383,296 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
61,531 | $18,522,675 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
33,420 | $17,944,868 | |
| 5 | ARGX |
Argenx SE
|
11,164 | $10,357,623 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
33,808 | $9,634,265 | |
| 7 | RPRX |
Royalty Pharma plc
|
150,556 | $8,441,674 | |
| 8 | INCY |
Incyte Corp
|
63,812 | $7,233,728 |
All Filings in NAMS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $177,176 | 5,228 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $191,963 | 5,997 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $193,290 | 5,510 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $123,827 | 4,354 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $78,543 | 4,337 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $75,227 | 3,675 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $79,130 | 3,079 | Shares | Sole | 2025-01-27 | |
| No filing history on record for this holder in this stock. | ||||||